The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Eunjung | - |
dc.contributor.author | Ko, Gang-Jee | - |
dc.date.accessioned | 2022-02-25T01:49:53Z | - |
dc.date.available | 2022-02-25T01:49:53Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 2075-4418 | - |
dc.identifier.issn | 2075-4418 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/55271 | - |
dc.description.abstract | Contrast-induced nephropathy (CIN) is an impairment of renal function that occurs after the administration of an iodinated contrast medium (CM). Kidney dysfunction in CIN is considered transient and reversible in most cases. However, it is the third most common cause of hospital-acquired acute kidney injury and is associated with increased morbidity and mortality, especially in high-risk patients. Diagnostic and interventional procedures that require intravascular CM are being used with increasing frequency, especially among the elderly, who can be particularly susceptible to CIN due to multiple comorbidities. Therefore, identifying the exact mechanisms of CIN and its associated risk factors is crucial not only to provide optimal preventive management for at-risk patients, but also to increase the feasibility of diagnostic and interventional procedure that use CM. CM induces kidney injury by impairing renal hemodynamics and increasing the generation of reactive oxygen species, in addition to direct cytotoxicity. Periprocedural hydration is the most widely accepted preventive strategy to date. Here, we review the latest research results on the pathophysiology and management of CIN. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/diagnostics12010180 | - |
dc.identifier.scopusid | 2-s2.0-85123222308 | - |
dc.identifier.wosid | 000746142700001 | - |
dc.identifier.bibliographicCitation | Diagnostics, v.12, no.1 | - |
dc.citation.title | Diagnostics | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | CONTRAST-INDUCED NEPHROPATHY | - |
dc.subject.keywordPlus | ACUTE KIDNEY INJURY | - |
dc.subject.keywordPlus | PERCUTANEOUS CORONARY INTERVENTION | - |
dc.subject.keywordPlus | HIGH-RISK PATIENTS | - |
dc.subject.keywordPlus | INTRAVENOUS CONTRAST | - |
dc.subject.keywordPlus | RENAL-INSUFFICIENCY | - |
dc.subject.keywordPlus | PROPHYLACTIC HYDRATION | - |
dc.subject.keywordPlus | GUIDED HYDRATION | - |
dc.subject.keywordPlus | N-ACETYLCYSTEINE | - |
dc.subject.keywordPlus | RANDOMIZED-TRIAL | - |
dc.subject.keywordAuthor | acute kidney injury | - |
dc.subject.keywordAuthor | contrast-induced nephropathy | - |
dc.subject.keywordAuthor | risk factor | - |
dc.subject.keywordAuthor | pathogenesis | - |
dc.subject.keywordAuthor | oxidative stress | - |
dc.subject.keywordAuthor | prevention | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.